UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.6% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
9076
Skyline Builders Group
KAZR
$23.5M
| $3.46K | ﹤0.01% |
1,121
-20,814
| -95% | -$69.1K |
2025 Q1
5 quarters
|
|
9077
Schwab Municipal Bond ETF
SCMB
$4.09B
| $3.46K | ﹤0.01% |
134
-153
| -53% | -$3.92K |
2026 Q1
1 quarter
|
|
9078
Alliance Entertainment
AENT
$228M
| $3.45K | ﹤0.01% |
591
-117
| -17% | -$761 |
2025 Q4
2 quarters
|
|
9079
Blue Acquisition Corp Right
BACCR
| $3.45K | ﹤0.01% |
+4,418
| New | +$1.53K |
2026 Q2
0 quarters
|
|
9080
Blue Acquisition Corp Unit
BACCU
| $3.44K | ﹤0.01% |
306
| – | – |
2025 Q4
2 quarters
|
|
9081
Basel Medical
BMGL
$73.3M
| $3.44K | ﹤0.01% |
495
-593
| -55% | -$4.36K |
2025 Q2
4 quarters
|
|
9082
Sequoia Global Value ETF
SFGV
$1.19B
| $3.44K | ﹤0.01% |
+98
| New | +$3.39K |
2026 Q2
0 quarters
|
|
9083
bioAffinity Technologies
BIAF
$1.36M
| $3.41K | ﹤0.01% |
280
-334
| -54% | -$10.2K |
2026 Q1
1 quarter
|
|
9084
Polaryx Therapeutics Inc
PLYX
$96.7M
| $3.41K | ﹤0.01% |
1,283
-12,196
| -90% | -$47.9K |
2026 Q1
1 quarter
|
|
9085
PIMCO Mortgage-Backed Securities Active Exchange-Traded Fund
PMBS
$1.44B
| $3.41K | ﹤0.01% |
69
| – | – |
2024 Q3
7 quarters
|
|
9086
Bluemonte Global Equity ETF
BINT
$420M
| $3.41K | ﹤0.01% |
+105
| New | +$3.32K |
2026 Q2
0 quarters
|
|
9087
Fidelity Fundamental Developed International ETF
FFDI
$18.6M
| $3.4K | ﹤0.01% |
+104
| New | +$3.31K |
2026 Q2
0 quarters
|
|
9088
BT Brands
BTBD
$10.1M
| $3.4K | ﹤0.01% |
3,175
-2,646
| -45% | -$3.82K |
2024 Q2
8 quarters
|
|
9089
Goldman Sachs Innovate Equity ETF
GINN
$177M
| $3.39K | ﹤0.01% |
43
+26
| +153% | +$1.98K |
2026 Q1
1 quarter
|
|
9090
Direxion Daily Dow Jones Internet Bear 3X ETF
WEBS
$7.61M
| $3.37K | ﹤0.01% |
174
-1
| -0.6% | -$20 |
2026 Q1
1 quarter
|
|
9091
MoneyHero
MNY
$25.1M
| $3.35K | ﹤0.01% |
3,843
+2,820
| +276% | +$3.61K |
2024 Q3
7 quarters
|
|
9092
Vendome Acquisition Corp I Unit
VNMEU
| $3.35K | ﹤0.01% |
325
+10
| +3% | +$103 |
2025 Q4
2 quarters
|
|
9093
FT Vest U.S. Equity Buffer & Digital Return ETF - October
DGOC
$4.95M
| $3.35K | ﹤0.01% |
103
| – | – |
2026 Q1
1 quarter
|
|
9094
Alger Russell Innovation ETF
INVN
$10.8M
| $3.34K | ﹤0.01% |
+156
| New | +$3.18K |
2026 Q2
0 quarters
|
|
9095
Trulieve Cannabis Corp
TRLV
$1.88B
| $3.33K | ﹤0.01% |
+339
| New | +$3.27K |
2026 Q2
0 quarters
|
|
9096
Innovator US Equity Buffer ETF September
BSEP
$456M
| $3.32K | ﹤0.01% |
63
-165
| -72% | -$8.5K |
2026 Q1
1 quarter
|
|
9097
LZ Technology Holdings
LZMH
$7.74M
| $3.32K | ﹤0.01% |
2,742
+2,652
| +2,947% | +$16.3K |
2025 Q1
5 quarters
|
|
9098
GSR IV Acquisition Corp Units
GSRFU
$215M
| $3.32K | ﹤0.01% |
323
-3
| -0.9% | -$31 |
2026 Q1
1 quarter
|
|
9099
Matthews Korea Active ETF
MKOR
$113M
| $3.32K | ﹤0.01% |
50
-139
| -74% | -$8.3K |
2026 Q1
1 quarter
|
|
9100
WisdomTree US Efficient Core Fund
NTSX
$1.34B
| $3.31K | ﹤0.01% |
+56
| New | +$3.22K |
2026 Q2
0 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,282 new, 4,216 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,282 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.